Treatment of rheumatoid arthritis

Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association
M E Weinblatt, A L Maier

Abstract

The management of the rheumatoid patient involves the considered use of pharmacologic agents as therapies to induce symptomatic relief and to reduce disease activity. Aspirin and nonsteroidal antiinflammatory drugs are used initially to lessen the degree of pain and swelling associated with the inflammatory disease process. The aggressive institution of second-line therapy, previously known as disease-modifying antiinflammatory rheumatic drugs, is advocated to modify the disease course itself. These second-line treatments include antimalarials, gold salts, methotrexate, d-penicillamine, and azathioprine. Randomized placebo controlled trials have demonstrated the efficacy of these compounds in this illness. Improvement in standard parameters of disease activity (number of painful and swollen joints, duration of morning stiffness, erythrocyte sedimentation rate) can be related to the therapeutic value of second-line agents. Whether they modify radiographic progression is under rigorous study. Newer therapies under research investigation include sulfasalazine, cyclosporin A, and combination therapy.

References

Jun 1, 1978·Agents and Actions·B McConkeyL Walsh
Aug 1, 1979·Arthritis and Rheumatism·M H Weisman, D M Hannifin
Apr 1, 1976·Southern Medical Journal·R CadeG Spooner
Jun 1, 1976·Annals of the Rheumatic Diseases·A E FinkelsteinA Misher
Jan 1, 1975·Arthritis and Rheumatism·T HunterM A Ogryzlo
Dec 1, 1986·Arthritis and Rheumatism·R S PinalsB Hepburn
May 1, 1988·Seminars in Arthritis and Rheumatism·R S Pinals
May 1, 1986·Seminars in Arthritis and Rheumatism·H E Howard-LockW F Kean
Jul 1, 1988·Journal of the American Academy of Dermatology·M E Weinblatt, J M Kremer
Jul 1, 1988·Journal of the American Academy of Dermatology·H H RoenigkG D Weinstein
Dec 1, 1988·Annals of Internal Medicine·D E YocumC Yarboro
Jan 1, 1988·Mayo Clinic Proceedings·S E Gabriel, H S Luthra
Feb 1, 1988·Arthritis and Rheumatism·M E WeinblattJ S Coblyn
Feb 1, 1988·Annals of the Rheumatic Diseases·M DougadosB Amor
Sep 1, 1986·Annals of the Rheumatic Diseases·A W van RijthovenA Cats
Jan 1, 1987·Arthritis and Rheumatism·M Dougados, B Amor
Feb 1, 1987·Seminars in Arthritis and Rheumatism·W Maksymowych, A S Russell
Jan 1, 1987·Arthritis and Rheumatism·M E WeinblattK F Austen
Feb 1, 1987·Seminars in Arthritis and Rheumatism·C W CarsonD O Clegg
Nov 1, 1985·Seminars in Arthritis and Rheumatism·S K MacKinnonR F Willkens
Mar 28, 1985·The New England Journal of Medicine·M E WeinblattD E Trentham
May 1, 1985·British Journal of Rheumatology·P W ThompsonC G Barnes
Sep 1, 1985·The American Journal of Medicine·A WeinsteinF Farouhar
Jan 1, 1974·Annals of Internal Medicine·J W SiglerW R McCrum
May 1, 1973·Arthritis and Rheumatism·M B UrowitzM A Ogryzio
Feb 15, 1969·British Medical Journal·M MasonI D Strickland
Jul 1, 1972·Annals of the Rheumatic Diseases·R C GerberC M Pearson
Nov 20, 1971·British Medical Journal·J HarrisD M Chaput de Saintonge
Feb 16, 1980·British Medical Journal·B McConkeyL Walsh

❮ Previous
Next ❯

Citations

Apr 27, 2000·The American Journal of Medicine·L Calabrese, A B Fleischer
Jun 9, 2020·Clinical Rheumatology·Satoshi MizutaniHidekata Yasuoka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.